CN101701962A - 一种血清镁标准物质 - Google Patents
一种血清镁标准物质 Download PDFInfo
- Publication number
- CN101701962A CN101701962A CN 200910237608 CN200910237608A CN101701962A CN 101701962 A CN101701962 A CN 101701962A CN 200910237608 CN200910237608 CN 200910237608 CN 200910237608 A CN200910237608 A CN 200910237608A CN 101701962 A CN101701962 A CN 101701962A
- Authority
- CN
- China
- Prior art keywords
- magnesium
- serum
- standard
- serum solution
- operation liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000002966 serum Anatomy 0.000 title claims abstract description 495
- 239000011777 magnesium Substances 0.000 title claims abstract description 435
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 title claims abstract description 434
- 229910052749 magnesium Inorganic materials 0.000 title claims abstract description 434
- 239000000126 substance Substances 0.000 title claims abstract description 109
- 239000000243 solution Substances 0.000 claims description 339
- 239000007788 liquid Substances 0.000 claims description 114
- 238000000034 method Methods 0.000 claims description 103
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 70
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 70
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 69
- 239000008367 deionised water Substances 0.000 claims description 59
- 229910021641 deionized water Inorganic materials 0.000 claims description 59
- 239000000463 material Substances 0.000 claims description 41
- 238000002835 absorbance Methods 0.000 claims description 37
- 239000001103 potassium chloride Substances 0.000 claims description 35
- 235000011164 potassium chloride Nutrition 0.000 claims description 35
- 239000011780 sodium chloride Substances 0.000 claims description 35
- 239000000203 mixture Substances 0.000 claims description 34
- 238000005303 weighing Methods 0.000 claims description 31
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 30
- 238000010790 dilution Methods 0.000 claims description 30
- 239000012895 dilution Substances 0.000 claims description 30
- 230000008569 process Effects 0.000 claims description 28
- 239000012530 fluid Substances 0.000 claims description 25
- 239000012749 thinning agent Substances 0.000 claims description 24
- 238000002156 mixing Methods 0.000 claims description 22
- ICAKDTKJOYSXGC-UHFFFAOYSA-K lanthanum(iii) chloride Chemical compound Cl[La](Cl)Cl ICAKDTKJOYSXGC-UHFFFAOYSA-K 0.000 claims description 20
- 239000000654 additive Substances 0.000 claims description 16
- 230000000996 additive effect Effects 0.000 claims description 16
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 claims description 13
- 229910001425 magnesium ion Inorganic materials 0.000 claims description 13
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 12
- MRELNEQAGSRDBK-UHFFFAOYSA-N lanthanum(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[La+3].[La+3] MRELNEQAGSRDBK-UHFFFAOYSA-N 0.000 claims description 12
- 238000006243 chemical reaction Methods 0.000 claims description 11
- 238000011160 research Methods 0.000 claims description 11
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 claims description 7
- RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 claims description 7
- 239000000174 gluconic acid Substances 0.000 claims description 7
- 235000012208 gluconic acid Nutrition 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 7
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 6
- 201000010099 disease Diseases 0.000 claims description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 5
- 238000000705 flame atomic absorption spectrometry Methods 0.000 claims description 5
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 238000012417 linear regression Methods 0.000 claims description 4
- 206010018910 Haemolysis Diseases 0.000 claims description 3
- 206010023126 Jaundice Diseases 0.000 claims description 3
- 210000001268 chyle Anatomy 0.000 claims description 3
- 230000001419 dependent effect Effects 0.000 claims description 3
- 230000008588 hemolysis Effects 0.000 claims description 3
- 230000003907 kidney function Effects 0.000 claims description 3
- 230000003908 liver function Effects 0.000 claims description 3
- 239000007791 liquid phase Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 abstract description 38
- 239000011159 matrix material Substances 0.000 abstract description 7
- 238000003860 storage Methods 0.000 abstract description 6
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 238000007865 diluting Methods 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 229940091250 magnesium supplement Drugs 0.000 description 339
- 239000000523 sample Substances 0.000 description 211
- 238000005259 measurement Methods 0.000 description 87
- 230000008014 freezing Effects 0.000 description 46
- 238000007710 freezing Methods 0.000 description 46
- 239000011550 stock solution Substances 0.000 description 24
- 238000012360 testing method Methods 0.000 description 22
- 238000004364 calculation method Methods 0.000 description 14
- 239000003153 chemical reaction reagent Substances 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 12
- 239000012925 reference material Substances 0.000 description 12
- 238000004458 analytical method Methods 0.000 description 10
- 230000008520 organization Effects 0.000 description 10
- 239000008151 electrolyte solution Substances 0.000 description 9
- 238000011010 flushing procedure Methods 0.000 description 9
- 238000001514 detection method Methods 0.000 description 8
- 238000001914 filtration Methods 0.000 description 8
- 239000003792 electrolyte Substances 0.000 description 7
- 230000003203 everyday effect Effects 0.000 description 7
- 239000011521 glass Substances 0.000 description 7
- 238000005070 sampling Methods 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 6
- 238000007796 conventional method Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000003908 quality control method Methods 0.000 description 6
- 238000013112 stability test Methods 0.000 description 6
- 239000010421 standard material Substances 0.000 description 6
- 210000005239 tubule Anatomy 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 4
- 238000000540 analysis of variance Methods 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- 230000005540 biological transmission Effects 0.000 description 4
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 4
- 230000005477 standard model Effects 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 108010003272 Hyaluronate lyase Proteins 0.000 description 3
- 230000002421 anti-septic effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000001739 density measurement Methods 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 238000013401 experimental design Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 230000010076 replication Effects 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 229910052805 deuterium Inorganic materials 0.000 description 2
- 239000012470 diluted sample Substances 0.000 description 2
- 238000003113 dilution method Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 239000000446 fuel Substances 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000003760 magnetic stirring Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- DBSMLQTUDJVICQ-CJODITQLSA-N onametostat Chemical compound NC1=C2C=CN([C@@H]3C[C@H](CCC4=CC=C5C=C(Br)C(N)=NC5=C4)[C@@H](O)[C@H]3O)C2=NC=N1 DBSMLQTUDJVICQ-CJODITQLSA-N 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 238000007430 reference method Methods 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 238000007492 two-way ANOVA Methods 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 241001269238 Data Species 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 101100489867 Mus musculus Got2 gene Proteins 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 238000002946 Total quality control Methods 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- GRTOGORTSDXSFK-XJTZBENFSA-N ajmalicine Chemical compound C1=CC=C2C(CCN3C[C@@H]4[C@H](C)OC=C([C@H]4C[C@H]33)C(=O)OC)=C3NC2=C1 GRTOGORTSDXSFK-XJTZBENFSA-N 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000012482 calibration solution Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- HGAZMNJKRQFZKS-UHFFFAOYSA-N chloroethene;ethenyl acetate Chemical compound ClC=C.CC(=O)OC=C HGAZMNJKRQFZKS-UHFFFAOYSA-N 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000010219 correlation analysis Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000001755 magnesium gluconate Substances 0.000 description 1
- 229960003035 magnesium gluconate Drugs 0.000 description 1
- 235000015778 magnesium gluconate Nutrition 0.000 description 1
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000004220 muscle function Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 239000013062 quality control Sample Substances 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
时间 | 血清溶液样品1 | 血清溶液样品2 | 血清溶液样品3 | 血清溶液样品4 | 血清溶液样品5 |
0天 | 14.09 | 21.20 | 29.47 | 37.69 | 43.59 |
30天 | 14.30 | 21.15 | 29.30 | 37.21 | 43.37 |
90天 | 14.19 | 21.17 | 29.38 | 37.51 | 43.48 |
180天 | 14.19 | 21.18 | 29.36 | 37.48 | 43.36 |
血清 | 均值 | 标准差 | CV(%) |
血清溶液样品1 | 12.13 | 0.17 | 1.40 |
血清溶液样品2 | 19.16 | 0.28 | 1.45 |
血清溶液样品3 | 26.44 | 0.27 | 1.02 |
血清 | 均值 | 标准差 | CV(%) |
血清溶液样品4 | 33.76 | 0.37 | 1.11 |
血清溶液样品5 | 40.97 | 0.35 | 0.85 |
血清 | 均值 | 标准差 | CV(%) |
血清溶液样品1 | 19.47 | 0.235 | 1.21 |
血清溶液样品2 | 26.94 | 0.213 | 0.80 |
血清溶液样品3 | 34.23 | 0.285 | 0.84 |
血清溶液样品4 | 41.51 | 0.324 | 0.78 |
血清溶液样品5 | 48.58 | 0.416 | 0.86 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009102376085A CN101701962B (zh) | 2009-11-19 | 2009-11-19 | 一种血清镁标准物质 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009102376085A CN101701962B (zh) | 2009-11-19 | 2009-11-19 | 一种血清镁标准物质 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101701962A true CN101701962A (zh) | 2010-05-05 |
CN101701962B CN101701962B (zh) | 2013-05-01 |
Family
ID=42156883
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009102376085A Active CN101701962B (zh) | 2009-11-19 | 2009-11-19 | 一种血清镁标准物质 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101701962B (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104965092A (zh) * | 2015-06-04 | 2015-10-07 | 广州金域医学检验中心有限公司 | 一种金属元素全血质控品的制备方法 |
CN106769953A (zh) * | 2017-03-23 | 2017-05-31 | 苏州泰事达检测技术有限公司 | 一种测定奥美拉唑镁原料药中的镁含量的方法 |
CN106908291A (zh) * | 2017-02-17 | 2017-06-30 | 嘉兴博泰生物科技发展有限公司 | 一种血清葡萄糖标准物质的制备方法 |
CN107923902A (zh) * | 2015-07-06 | 2018-04-17 | 富士胶片株式会社 | 血液检查试剂盒及血液分析方法 |
CN108776055A (zh) * | 2018-07-18 | 2018-11-09 | 山西医科大学 | 一种血铝的标准物质及应用 |
CN109324147A (zh) * | 2018-11-02 | 2019-02-12 | 首都医科大学附属北京朝阳医院 | 一种同时检测血清电解质钠、钾、镁、钙离子的方法及其专用候选标准物质 |
CN110849830A (zh) * | 2019-11-15 | 2020-02-28 | 首都医科大学附属北京朝阳医院 | 一种血清铜的标准物质及其制备方法与应用 |
US20210405076A1 (en) * | 2018-05-24 | 2021-12-30 | C Technologies Inc. | Slope spectroscopy standards |
-
2009
- 2009-11-19 CN CN2009102376085A patent/CN101701962B/zh active Active
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104965092A (zh) * | 2015-06-04 | 2015-10-07 | 广州金域医学检验中心有限公司 | 一种金属元素全血质控品的制备方法 |
CN107923902A (zh) * | 2015-07-06 | 2018-04-17 | 富士胶片株式会社 | 血液检查试剂盒及血液分析方法 |
US10823745B2 (en) | 2015-07-06 | 2020-11-03 | Fujifilm Corporation | Blood test kit and blood analysis method |
CN106908291A (zh) * | 2017-02-17 | 2017-06-30 | 嘉兴博泰生物科技发展有限公司 | 一种血清葡萄糖标准物质的制备方法 |
CN106769953A (zh) * | 2017-03-23 | 2017-05-31 | 苏州泰事达检测技术有限公司 | 一种测定奥美拉唑镁原料药中的镁含量的方法 |
US20210405076A1 (en) * | 2018-05-24 | 2021-12-30 | C Technologies Inc. | Slope spectroscopy standards |
US11789031B2 (en) * | 2018-05-24 | 2023-10-17 | C Technologies Inc. | Slope spectroscopy standards |
CN108776055A (zh) * | 2018-07-18 | 2018-11-09 | 山西医科大学 | 一种血铝的标准物质及应用 |
CN109324147A (zh) * | 2018-11-02 | 2019-02-12 | 首都医科大学附属北京朝阳医院 | 一种同时检测血清电解质钠、钾、镁、钙离子的方法及其专用候选标准物质 |
CN110849830A (zh) * | 2019-11-15 | 2020-02-28 | 首都医科大学附属北京朝阳医院 | 一种血清铜的标准物质及其制备方法与应用 |
Also Published As
Publication number | Publication date |
---|---|
CN101701962B (zh) | 2013-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101701962B (zh) | 一种血清镁标准物质 | |
CN101930009B (zh) | 一种血清钙标准物质 | |
Spichiger-Keller | Chemical sensors and biosensors for medical and biological applications | |
Entwisle et al. | Liquid chromatographic method with immunoaffinity column cleanup for determination of ochratoxin A in barley: collaborative study | |
CN101271072B (zh) | 一种四苯硼钠比浊法测定土壤中钾的方法及其掩蔽剂 | |
Schultz et al. | Determination of vitamin B1 by yeast fermentation method improvements related to use of sulfite cleavage and a new fermentometer | |
CN101097181A (zh) | 试样分析用试剂、试样分析用试剂盒及试样分析方法 | |
CN104251841A (zh) | 基于光腔衰荡光谱的多样本呼吸分析仪 | |
CN110849830A (zh) | 一种血清铜的标准物质及其制备方法与应用 | |
CN106226425A (zh) | 血清糖化白蛋白检测方法及其专用候选标准物质 | |
CN105758700B (zh) | 葡萄糖-6-磷酸脱氢酶冻干全血质控品及其制备方法 | |
CN110057763A (zh) | 用分光光度法测定碳酸钠中硫酸盐的含量的方法 | |
CN104897766A (zh) | 一种用同位素稀释质谱法测定样品中痕量元素的校正方法 | |
CN112083175A (zh) | 一种全自动干式生化仪测定的溶血指数对生化指标进行校正的方法 | |
CN102305824B (zh) | 一种准确测定血清钾的方法 | |
Jeong et al. | Recent trends in creatinine assays in Korea: long-term accuracy-based proficiency testing survey data by the Korean Association of External Quality Assessment Service (2011-2019) | |
CN111122463A (zh) | 一种用于个体碘营养评价的微量血清样本中碘离子的无砷检测方法 | |
Gunaratna et al. | Frozen human serum reference material for standardization of sodium and potassium measurements in serum or plasma by ion-selective electrode analyzers | |
CN107247092A (zh) | 一种快速定量检测植物及食品中无机硒含量的方法 | |
CN107991375A (zh) | 一种测定人体尿液中碘元素的试剂盒 | |
CN109324147B (zh) | 一种同时检测血清电解质钠、钾、镁、钙离子的方法及其专用候选标准物质 | |
JP6635814B2 (ja) | 微量かつ未知量体液の分析方法 | |
Sirchia et al. | Statistical evaluation of the determination of red cell acetylcholinesterase activity | |
Mellon | Fisher award address: a century of colorimetry | |
CN109097453A (zh) | 一种rna核酸类定值质控物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Qingtao Inventor after: Wang Jinying Inventor after: Ma Huaian Inventor after: Li Huiling Inventor after: Xu Jing Inventor after: Jia Huimin Inventor after: Tong Qing Inventor before: Wang Jinying Inventor before: Li Huiling Inventor before: Ma Huaian Inventor before: Xu Jing Inventor before: Jia Huimin Inventor before: Tong Qing |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: WANG JINYING LI HUILING MA HUAIAN XU JING JIA HUIMIN TONG QING TO: WANG QINGTAO WANG JINYING MA HUAIAN LI HUILING XU JING JIA HUIMIN TONG QING |